Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

2026-04-05 13:03:55

Abstract generation in progress

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on behalf of investors who purchased securities before March 29, 2024. The investigation seeks to determine if Unicycive and its officers engaged in corporate wrongdoing. Shareholders are encouraged to contact the firm for more information and to assist with the investigation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.